News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity


4/24/2012 10:35:00 AM

CONCORD, Calif. & NEW YORK--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) and New York Blood Center (NYBC) announced today that they have entered into a research collaboration to explore the possibility of creating a red blood cell (RBC) biologic product with improved uniformity compared to a standard unit of red blood cells.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES